A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders

被引：71

作者：

Schmidt, DW ^{[1
]}

Bremner, T ^{[1
]}

Orris, JJ ^{[1
]}

Maier, DB ^{[1
]}

Benadiva, CA ^{[1
]}

Nulsen, JC ^{[1
]}

机构：

[1] Univ Connecticut, Ctr Hlth, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil,Ctr Adv Reprod S, Farmington, CT 06030 USA

来源：

FERTILITY AND STERILITY | 2005年 / 83卷 / 05期

关键词：

D O I：

10.1016/j.fertnstert.2004.10.053

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Forty-eight patients who met the criteria of poor response during prior gonadotropin stimulation were enrolled in a randomized prospective study comparing a gonadotropin-releasing hormone (GnRH) antagonist protocol, using ganirelix acetate, with a microdose GnRH agonist protocol for in vitro fertilization-embryo transfer (IVF-ET). This pilot study contributes to the literature of poor response IVF treatment protocols because the use of ganirelix appears to be as effective as the microdose protocol and may be a superior choice in terms of cost and convenience for the patient. (Fertil Steril (R) 2005;83:1568-71. (c) 2005 by American Society for Reproductive Medicine.)

引用

页码：1568 / 1571

页数：4

共 50 条

[21] Late initiation of gonadotrophin administration after microdose flare up increases response in poor responders - A randomized prospective study.
Gunaydin, G.
Oktem, M.
Gumuslu, S.
Erdem, A.
Guner, H.
Karabacak, O.
FERTILITY AND STERILITY, 2007, 88 : S100 - S101
[22] Investigating apoptotic, inflammatory, and growth markers in poor responders undergoing natural in vitro fertilization cycles: a pilot study
Sfakianoudis, Konstantinos
Tsioulou, Petroula
Maziotis, Evangelos
Grigoriadis, Sokratis
Glava, Argyro
Nitsos, Nikolaos
Giannelou, Polina
Makrakis, Evangelos
Pantou, Agni
Rapani, Anna
Koutsilieris, Michael
Mastorakos, George
Pantos, Konstantinos
Simopoulou, Mara
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2021, 1489 (01) : 78 - 90
[23] Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization
Surrey, ES
Bower, J
Hill, DM
Ramsey, J
Surrey, MW
FERTILITY AND STERILITY, 1998, 69 (03) : 419 - 424
[24] Patient survey data from a prospective randomized controlled trial comparing the use of NuvaRing® to Desogen® in in vitro fertilization cycles with ganirelix acetate.
Karande, VC
Birkenkamp, T
Cavanaugh, J
Melone, K
Hazlett, D
FERTILITY AND STERILITY, 2005, 83 : S21 - S21
[25] Validity of high-dose gonadotropins for induction of ovulation in poor responders for in vitro fertilization cycles
Madankumar, R
Kenigsberg, D
Brenner, S
OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 99S - 99S
[26] Corifollitropin alfa for poor responders patients, a prospective randomized study
Fusi, F. M.
Zanga, L.
Arnoldi, M.
Melis, S.
Cappato, M.
Candeloro, I.
Di Pasqua, A.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2020, 18 (01)
[27] Corifollitropin alfa for poor responders patients, a prospective randomized study
F. M. Fusi
L. Zanga
M. Arnoldi
S. Melis
M. Cappato
I. Candeloro
A. Di Pasqua
Reproductive Biology and Endocrinology, 18
[28] A comparison of microdose flare protocol versus AACEP protocol for IVF poor responders
Quintero, R.
Yap, R.
Lopez, M.
Acacio, B.
Nouriani, M.
FERTILITY AND STERILITY, 2008, 89 : S25 - S25
[29] Monitoring of in vitro fertilization-embryo transfer cycles by ultrasound versus by ultrasound and hormonal levels: a prospective, multicenter, randomized study
Lass, A
FERTILITY AND STERILITY, 2003, 80 (01) : 80 - 85
[30] In Vitro Fertilization Outcomes in Donor Oocyte Cycles Compared to the Autologous Cycles in the Poseidon 4 Group of Poor Ovarian Responders
Havrljenko, Jelena
Kopitovic, Vesna
Pjevic, Aleksandra Trninic
Milatovic, Stevan
Kalember, Sandro
Katanic, Filip
Pavlica, Tatjana
Andric, Nebojsa
Pogrmic-Majkic, Kristina
MEDICINA-LITHUANIA, 2025, 61 (02):

← 1 2 3 4 5 →